Board Director and Advisor, Healthcare and Life Sciences 

Dr. Lisa Egbuonu-Davis is an independent board director and strategic advisor with leadership experience across biopharmaceuticals, diagnostics, MedTech, and public health. Throughout her career, she has translated clinical, scientific, and public health insights into product, investment, and healthcare strategy, with a particular focus on evidence generation, patient outcomes, healthcare value, affordability, and population health. 

She currently serves on the boards of Phreesia (NYSE: PHR) and Omega Healthcare Investors (NYSE: OHI), and recently served on the board of Avanos Medical (NYSE: AVNS), which was acquired by private equity in July 2026. She is also a trustee of Johns Hopkins Medicine, a member of the Johns Hopkins University School of Education National Advisory Committee, and an advisor through LED Enterprise LLC. 

Previously, at Danaher’s DH Diagnostics affiliate, Dr. Egbuonu-Davis led research, partnership, and investment strategy initiatives across the diagnostics portfolio, including programs focused on COVID-19 and Alzheimer’s disease. She also served as Interim Chief Medical Officer for Beckman Coulter and Leica. At Sanofi, she developed patient programs and tools designed to improve adherence and outcomes in chronic disease. At Pfizer, as Vice President of U.S. Medical Operations and Vice President of Global Outcomes Research, she led clinical and outcomes research, developed payer value frameworks, and helped guide investment decisions across a broad therapeutic portfolio. 

Earlier in her career, she advised biopharmaceutical companies and trade associations at Avalere Health and Booz Allen on healthcare reform, technology assessment, and quality strategy. Across these roles, she has focused on aligning innovation, evidence, incentives, and investment to improve health outcomes while advancing affordability and sustainability in healthcare. 

Dr. Egbuonu-Davis holds an MD and MPH in Epidemiology from Johns Hopkins University, an MBA in Health Care Management from The Wharton School, and is board-certified in Pediatrics.